Medical Innovation Exchange

VC firm LifeArc sells first portfolio company as dermatitis-focused Ducentis bought by Arcutis for $30M

https://www.fiercebiotech.com/biotech/vc-firm-lifearc-sells-first-portfolio-company-dermatitis-focused-ducentis-bought-arcutis

Leave a Comment

Your email address will not be published.

Leave the field below empty!